Home
Conditions
Lung Neoplasms

Clinical trial condition

Lung Neoplasms

Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.

4,211 public trials 1,007 recruiting studies

Refine in advanced search Browse all conditions

Lung Neoplasms trial results

Enrolling by Invitation

Liquid BiOpsy, Lung and Colon Cancer in AndaluciA

NCT06997458

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +22 more
Locations: Centre for Genomics and Oncological Research - Pfizer - University of Granada - Andalusian Regional Government (GENyO) Granada, Andalusia, Spain

View Trial Details

Enrolling by Invitation

Maintenance Durvalumab (MEDI4736) and Olaparib (AZD2281) After Standard 1st Line Treatment (Carboplatin/Cisplatin, Etoposide, Durvalumab) in HRD Positive Extensive Disease (ED) Small-cell Lung Cancer (SCLC)

NCT06419179

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +7 more
Locations: University Hospital Cologne Cologne, North Rhine-Westphalia, Germany

View Trial Details

Enrolling by Invitation

Real-World Assessment of Therapeutic Strategies and Survival Outcomes Following First-Line Tislelizumab Therapy in Advanced Non-Small Cell Lung Cancer

NCT06962449

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +13 more
Locations: Shanghai Chest Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Enrolling by Invitation

Evaluation of [18F]AlF-NOTA-PCP2 PET/CT for PD-L1 Detection in Malignant Tumors

NCT06690216

Conditions: Astrocytoma, Bronchial Neoplasms, Carcinoma, +30 more
Locations: Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences Jinan, Shandong, China

View Trial Details

Enrolling by Invitation

Efficacy and Safety of Sintilimab Combined with Platinum-containing Double-agent Chemotherapy in First-line Treatment of Locally Advanced or Metastatic Non-small Cell Lung Cancer in Elderly Patients

NCT06883136

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Degan Lu Jinan, Shandong, China

The First Affiliated Hospital of Shandong First Medical University Jinan, Shandong, China

View Trial Details

Enrolling by Invitation

LORLATINIB-related HYPERLIPIDEMIA in ALK+ Non-Small Cell Lung Cancer

NCT06876675

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +14 more
Locations: Peking University Third Hospital Beijing, China

View Trial Details

Enrolling by Invitation

Chemotherapy-immunotherapy-based Split-course Adaptive Hypofractionated Radiotherapy for Extensive-stage SCLC

NCT06816966

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations: Fujian Medical University Union Hospital, Fuzhou, Fujian, China

View Trial Details

Enrolling by Invitation

Adjuvant Adebrelimab Plus Apatinib After Chemoradiation in Limited-Stage Small Cell Lung Cancer

NCT06773156

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Limited-stage Small Cell Lung Cancer (LS-SCLC), +8 more
Locations: The Second Affiliated Hospital of Nanchang University Nanchang, Jiangxi, China

View Trial Details

Enrolling by Invitation

FHND9041 Versus Afatinib for Non-small Cell Lung Cancer

NCT06759857

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Cancer Hospital Chinese Academy of Medical Sciences Beijing, China

View Trial Details

Enrolling by Invitation

INK Cells As Maintenance Therapy After Chemoradiotherapy for Small Cell Lung Cancer

NCT06747832

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations: Weifang People's Hospital Weifang, Shandong Province, China., China

View Trial Details

Lung Neoplasms

Lung Neoplasms trial results

Related conditions